Referral Advantage: Clinical Quality with GIA®
Attracting hospital referrals requires demonstrating superior clinical quality. [GIA®](/gia) screens powered by [digitalhumanOS™](/platform) provide a competitive advantage.
Key Facts
- Demonstrating clinical quality is key to attracting hospital referrals.
- AI can improve outcomes and showcase facility performance.
- A strong referral network leads to increased occupancy and revenue.
Attracting hospital referrals requires demonstrating superior clinical quality. GIA® screens powered by digitalhumanOS™ provide a competitive advantage. By improving patient outcomes and showcasing facility performance through data-driven insights, facilities can strengthen their referral network, increase occupancy, and boost revenue.
Improved Outcomes
AI improves patient outcomes, enhancing the facility's reputation.
Performance Showcase
Showcase facility performance with data-driven insights effectively.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
Stronger Referrals
Attract more hospital referrals by demonstrating clinical quality.
Increased Occupancy
A strong referral network leads to increased occupancy and revenue.
Conclusion
GIA® screens using digitalhumanOS™ provide a referral advantage. Improve outcomes, showcase performance, and strengthen your referral network. Invest in clinical quality. See how GIA® improves referral quality with objective screening data.
Sources & References
- 94% of LTC facilities report understaffing. 47% at financial closure risk. Nurses spend 28.8% of time on documentation. Scienza Health proof point, sourced from internal operational data.
- Scienza Health internal validation: 12.3M longitudinal PAC/LTC patient records, 27B clinical events, 46 conditions screened.
- Wyoming Health Innovation Living Lab Case Study. 2024. Real-world validation of voice biomarker technology.
David Kaiser is the Founder and CEO of Scienza Health. He leads the development of GIA® and digitalhumanOS™, a clinically validated speech biomarker platform that screens for 46 cognitive and neurological conditions in under 5 minutes.
This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.
Frequently Asked Questions
How does AI improve outcomes?
By personalizing care and identifying potential issues early.
How can I showcase performance?
Through data-driven reports and dashboards.
What is the ROI?
Increased occupancy and revenue due to stronger referrals.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.